Press statement following meeting with Commission President Ursula von der Leyen on tariffs

9 April 2025

New Horizons for Biosimilar Medicines Policy: Delivering better access, outcomes, and biotech manufacturing in the future

3 April 2025

EU multiannual financial framework funding for critical medicines manufacturing vital for strategic autonomy

1 April 2025

IGBA Statement on trade barriers and their impact on healthcare systems and patients’ health

25 March 2025

Ambitious Critical Medicines Act vital to secure supply

11 March 2025

Medicines for Europe supports legal action against provisions in the Urban Wastewater Treatment Directive (UWWTD), which puts access to medicines at risk

10 March 2025

Pharma reform brings new opportunities for better regulation, access and security of medicines supply

27 February 2025

Harmonising Bioequivalence: Advancing Global Access to Generic Medicines

26 February 2025

PharmaBoardroom’s interview with President Stephan Eder

18 February 2025

President of Medicines for Europe, Stephan Eder, highlights the association’s […]

Biosimilar medicines: the intersection of access, affordability, and innovation

3 February 2025

Director of Biosimilar Policy & Science at Medicines for Europe, […]